Back to Journals » OncoTargets and Therapy » Volume 7
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,973 | Dovepress* | 9,506+ | 1,547 | 11,053 | |
PubMed Central* | 2,467 | 462 | 2,929 | ||
Totals | 11,973 | 2,009 | 13,982 | ||
*Since 4 October 2014 +Since July 2016 |
View citations on PubMed Central and Google Scholar